Both, ACE2 and TMPRSS2, have gained considerable importance and interest on their relevance in the pathogenicity of COVID-19, but these studies utilized samples from patients who were already infected with SARS-CoV-2 and did not have a reference sample from the same patient at another time. This evidence concerns the gene ACE2 and COVID-19.